https://scholars.lib.ntu.edu.tw/handle/123456789/525470
標題: | Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010-2019 | 作者: | Lee K.-L. Lee C.-M. Yang T.-L. TING-YU YEN LUAN-YIN CHANG JONG-MIN CHEN PING-ING LEE LI-MIN HUANG CHUN-YI LU |
公開日期: | 2021 | 出版社: | NLM (Medline) | 卷: | 120 | 期: | 1 | 起(迄)頁: | 281-291 | 來源出版物: | Journal of the Formosan Medical Association = Taiwan yi zhi | 摘要: | Background/Purpose: Despite the high prevalence of Mycoplasma pneumoniae infections, reports on severe life-threatening M. pneumoniae pneumonia (MPP) in children are limited. Methods: We retrospectively enrolled pediatric patients with PCR-positive MPP requiring ICU admission in a children's hospital in Taipei, Taiwan from Jun 2010 to October 2019. Clinical manifestations and laboratory data of severe MPP were analyzed. Macrolide susceptibility was determined by genotyping, and its relationship with clinical manifestations was also analyzed. Results: Approximately 5% (34/658) children hospitalized for MPP required ICU admission. Compared with non-ICU cases (n = 291), ICU cases (n = 34) were associated with more underlying conditions, more pleural effusion, longer fever duration, longer hospital stay, the requirement of second-line antibiotic treatment, and delayed effective and second-line antibiotic treatment. Macrolide resistance was similar in ICU and non-ICU groups (53% vs 53%; p = 0.986). In severe MPP, patients requiring endotracheal intubation were associated with more septic shock, empyema, ARDS, prolonged fever after effective antibiotic treatment, delayed second-line and effective antibiotic treatment. In 18 of the 22 patients with pleural fluid analysis, the pleural effusion was alkaline (pH > 7.7) and lymphocyte-predominant. Conclusion: M. pneumoniae infection can cause severe life-threatening pneumonia in children. Delayed effective and second-line antibiotic treatments are associated with severe life-threatening MPP. ? 2020 Formosan Medical Association |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097003790&doi=10.1016%2fj.jfma.2020.08.018&partnerID=40&md5=66b9cff0792c99a3942bc91927ccd248 https://scholars.lib.ntu.edu.tw/handle/123456789/525470 |
ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2020.08.018 | SDG/關鍵字: | antibiotic agent; doxycycline; macrolide; quinoline derived antiinfective agent; antiinfective agent; antibiotic sensitivity; antibiotic therapy; Article; child; clinical feature; controlled study; disease severity; empyema; endotracheal intubation; female; fever; human; human cell; intensive care; length of stay; lymphocyte; macrolide resistance; major clinical study; male; Mycoplasma pneumonia; pediatric patient; pleura effusion; pleura fluid; polymerase chain reaction; respiratory distress syndrome; retrospective study; septic shock; Taiwan; thorax radiography; antibiotic resistance; intensive care; Mycoplasma pneumonia; Mycoplasma pneumoniae; Anti-Bacterial Agents; Child; Critical Care; Drug Resistance, Bacterial; Humans; Macrolides; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Retrospective Studies; Taiwan |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。